GeneDesign joins Ajinomoto Bio-pharma

Ajinomoto Bio-Pharma, a leading provider of biopharmaceutical contract development and manufacturing services has a...

April 9, 2019 | Tuesday | News
Japan grants Sakigake designation to Eisai’s novel FGFR

Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. The co...

April 8, 2019 | Monday | News
Clinigen K.K., GC Pharma sign pact to market Hunterase ICV

Clinigen K.K. and GC Pharma have recently announced an exclusive licensing agreement in Japan to commercialize...

April 5, 2019 | Friday | News
Japan approves first drug for ADA deficiency

Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, has announced that it has acqui...

April 4, 2019 | Thursday | News
Takeda takes step towards EU Entyvio extension

Takeda Pharmaceutical Company Limited announced that the European Medicines Agency (EMA) has accepted a Marketing Author...

April 2, 2019 | Tuesday | News
Chugai Pharma sells Ulcerlmin business to Fuji Chemical

Chugai Pharmaceutical Co., Ltd., Tokyo and Fuji Chemical Industries Co., Ltd., Toyama announced that two companies ...

April 3, 2019 | Wednesday | News
Hitachi's Radiation Therapy Systems start operation in Nagamori Memorial Center

Hitachi, Ltd. has announced that the radiation therapy started on April 1, 2019 at Nagamori Memorial Center of Innovativ...

April 2, 2019 | Tuesday | News
GHIT selects joint research project on dengue by Chugai, A*STAR

Chugai Pharmaceutical Co., Ltd. has announced that a joint research project between Chugai and the Agency for Science, T...

April 2, 2019 | Tuesday | News
Takeda, StrideBio to advance novel gene therapies for neuro diseases

StrideBio, Inc, a leading developer of novel adeno-associated viral (AAV) based gene therapies, recently announced the s...

April 1, 2019 | Monday | News
Daiichi Sankyo, AstraZeneca sign $6.9M deal for cancer drug

Daiichi Sankyo Company, Limited has entered into a global development and commercialization agreement with AstraZeneca f...

March 29, 2019 | Friday | News
CPhI Japan sees Japanese R&D reinvigorated with international partnerships proliferating

CPhI Japan closes as a new wave of innovation is rising across the country, driven by structural and regulatory changes....

March 29, 2019 | Friday | News
Japan approves Gilead’s Biktarvy to treat HIV-1 Infection

Gilead Sciences, announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Bikta...

March 28, 2019 | Thursday | News
GHIT Fund announces new investment worth 2.86B Yen

The Global Health Innovative Technology (GHIT) Fund has announced a total of 2.86 billion yen to support 10 partnerships...

March 28, 2019 | Thursday | News
Japan Health Ministry approves immunoglobulins to treat CIDP

Global biotherapeutics leader CSL Behring recently announced that Japan's Ministry of Health, Labour and ...

March 28, 2019 | Thursday | News
AbbVie gets the first global regulatory approval of SKYRIZI in Japan

AbbVie, a research-based global biopharmaceutical company, has announced that the Japanese Ministry of Health, Labour an...

March 27, 2019 | Wednesday | News
Lupin, YL Biologics receive PMDA approval for Etanercept biosimilar in Japan

Lupin has announced that YL Biologics Limited (YLB), a joint venture between Lupin’s subsidiary Lupin Atlantis Hol...

March 26, 2019 | Tuesday | News
Eisai starts Phase III clinical trial for Alzheimer's drug

Eisai Co., Ltd. has announced that a global Phase III clinical study (Clarity AD/Study 301) of BAN2401, an anti-amyloid ...

March 25, 2019 | Monday | News
Eisai to present latest research on Alzheimer's Disease / Dementia Pipeline

Eisai Co., Ltd. announced that a total of seven presentations highlighting the latest data on its Alzheimer's disease/de...

March 22, 2019 | Friday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls